The PE Ratio as of December 2024 (TTM) for Forte Biosciences, Inc. (FBRX) is -1.21

According to Forte Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.21. This represents a change of 52.17% compared to the average of -0.80 of the last 4 quarters.

Forte Biosciences, Inc. (FBRX) Historical PE Ratio (quarterly & annually)

How has FBRX PE Ratio performed in the past?

The mean historical PE Ratio of Forte Biosciences, Inc. over the last ten years is -3.94. The current -1.21 PE Ratio has changed 2.97% with respect to the historical average. Over the past ten years (40 quarters), FBRX's PE Ratio was at its highest in in the September 2018 quarter at 29.83. The PE Ratio was at its lowest in in the June 2019 quarter at -60.22.

Forte Biosciences, Inc. (FBRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Forte Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Forte Biosciences, Inc. (FBRX) Average PE Ratio

How has FBRX PE Ratio performed in the past?

The current PE Ratio of Forte Biosciences, Inc. (FBRX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Forte Biosciences, Inc. (FBRX) PE Ratio vs. Peers

How is FBRX’s PE Ratio compared to its peers?

Forte Biosciences, Inc.’s PE Ratio is less than Indaptus Therapeutics, Inc. (-0.59), greater than Rezolute, Inc. (-4.39), less than Tempest Therapeutics, Inc. (-0.62), less than Comera Life Sciences Holdings, Inc. (-0.00), less than ABVC BioPharma, Inc. (-0.77), less than Pasithea Therapeutics Corp. (-0.18), less than Better Therapeutics, Inc. (-0.00), greater than ZIVO Bioscience, Inc. (-5.50), greater than Theseus Pharmaceuticals, Inc. (-6.29), greater than Erasca, Inc. (-4.59), less than Applied Molecular Transport Inc. (-0.43), less than Werewolf Therapeutics, Inc. (-1.07), greater than Edgewise Therapeutics, Inc. (-22.38), greater than Decibel Therapeutics, Inc. (-1.95), greater than Celcuity Inc. (-5.66), greater than C4 Therapeutics, Inc. (-2.49),

Build a custom stock screener for Forte Biosciences, Inc. (FBRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Forte Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Forte Biosciences, Inc. (FBRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Forte Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.